vs

Side-by-side financial comparison of Jefferson Capital, Inc. (JCAP) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $150.8M, roughly 1.3× Jefferson Capital, Inc.). Jefferson Capital, Inc. runs the higher net margin — 25.4% vs 6.7%, a 18.7% gap on every dollar of revenue. Jefferson Capital, Inc. produced more free cash flow last quarter ($63.0M vs $17.6M).

GE Capital was the financial services division of General Electric. Its various units were sold between 2013 and 2021, including the notable spin-off of the North American consumer finance division as Synchrony Financial. Ultimately, only one division of the company remained, GE Energy Financial Services, which was transferred to GE Vernova when General Electric was broken up.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

JCAP vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$150.8M
JCAP
Higher net margin
JCAP
JCAP
18.7% more per $
JCAP
25.4%
6.7%
RGEN
More free cash flow
JCAP
JCAP
$45.4M more FCF
JCAP
$63.0M
$17.6M
RGEN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
JCAP
JCAP
RGEN
RGEN
Revenue
$150.8M
$197.9M
Net Profit
$38.4M
$13.3M
Gross Margin
52.5%
Operating Margin
46.4%
9.0%
Net Margin
25.4%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.59
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JCAP
JCAP
RGEN
RGEN
Q4 25
$197.9M
Q3 25
$150.8M
$188.8M
Q2 25
$152.7M
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
JCAP
JCAP
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$38.4M
$14.9M
Q2 25
$47.7M
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
JCAP
JCAP
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
JCAP
JCAP
RGEN
RGEN
Q4 25
9.0%
Q3 25
46.4%
8.9%
Q2 25
56.7%
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
JCAP
JCAP
RGEN
RGEN
Q4 25
6.7%
Q3 25
25.4%
7.9%
Q2 25
31.2%
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
JCAP
JCAP
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.59
$0.26
Q2 25
$16.76
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JCAP
JCAP
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$42.3M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$437.4M
$2.1B
Total Assets
$1.8B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JCAP
JCAP
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$42.3M
$748.7M
Q2 25
$51.7M
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
JCAP
JCAP
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
JCAP
JCAP
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$437.4M
$2.1B
Q2 25
$410.8M
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
JCAP
JCAP
RGEN
RGEN
Q4 25
$2.9B
Q3 25
$1.8B
$2.9B
Q2 25
$1.8B
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
JCAP
JCAP
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JCAP
JCAP
RGEN
RGEN
Operating Cash FlowLast quarter
$63.1M
$25.7M
Free Cash FlowOCF − Capex
$63.0M
$17.6M
FCF MarginFCF / Revenue
41.7%
8.9%
Capex IntensityCapex / Revenue
0.1%
4.1%
Cash ConversionOCF / Net Profit
1.64×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JCAP
JCAP
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$63.1M
$48.1M
Q2 25
$130.6M
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
JCAP
JCAP
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$63.0M
$43.4M
Q2 25
$130.0M
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
JCAP
JCAP
RGEN
RGEN
Q4 25
8.9%
Q3 25
41.7%
23.0%
Q2 25
85.1%
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
JCAP
JCAP
RGEN
RGEN
Q4 25
4.1%
Q3 25
0.1%
2.5%
Q2 25
0.4%
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
JCAP
JCAP
RGEN
RGEN
Q4 25
1.93×
Q3 25
1.64×
3.23×
Q2 25
2.74×
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JCAP
JCAP

United States Segment$108.1M72%
Other$35.8M24%
United Kingdom Segment$6.9M5%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons